Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KW-136 Plus Sofosbuvir for Chronic Hepatitis C
NCT03416491Phase 2Completed
- Sponsor
- Beijing Kawin Technology Share-Holding Co., Ltd.
- Start
- Feb 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of coblopasvir in hepatitis C (HCV), sponsored by Beijing Kawin Technology Share-Holding Co., Ltd.. Started Feb 2017; status: completed.
02
Drugs
coblopasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT03416491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03416491.